What is the Prescient Therapeutics (ASX: PTX) share price?
The PTX share price is $0.065, down 4.41% for the day, based on the latest available ASX market data.
What is Prescient Therapeutics's market capitalisation?
Prescient Therapeutics has a market capitalisation of $68.3M, making it the 930th-largest security listed on the ASX.
Does Prescient Therapeutics pay a dividend?
PTX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Prescient Therapeutics profitable?
In its most recent reported period (ending 31 Dec 2025), PTX reported revenue of $0 and a net loss of $4.0M.
How many PTX shares are on issue?
Prescient Therapeutics has approximately 1,051,514,538 shares on issue, based on its market capitalisation of $68.3M and current share price.
What sector is Prescient Therapeutics in?
Prescient Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Prescient Therapeutics list on the ASX?
Prescient Therapeutics listed on the Australian Securities Exchange on 3 Jan 1999.
